ACRP CCRC Exam Prep: 100 Practice
Questions and Answers
This comprehensive practice exam is designed to help you prepare for
the ACRP Certified Clinical Research Coordinator (CCRC) exam. The
questions are based on the official ACRP Exam Content Outline (ECO)
which outlines the six domains tested on the exam.
EXAM OVERVIEW
The CCRC exam covers the following domains, with the percentage of
questions allocated to each domain as shown below:
Domain Percentag
e
I. Scientific 8%
Concepts and
Research Design
II. Ethical and 22%
Participant Safety
Considerations
,III. Product 14%
Development and
Regulation
IV. Clinical Trial 22%
Operations (GCPs)
V. Study and Site 22%
Management
VI. Data 12%
Management and
Informatics
SECTION 1: SCIENTIFIC CONCEPTS AND
RESEARCH DESIGN (Questions 1-8)
Question 1
Which document provides the detailed design of a clinical trial,
including the background, objectives, and statistical methods?
A. Investigator's Brochure (IB)
B. Case Report Form (CRF)
C. Protocol
D. Informed Consent Form (ICF)
Answer: C. Protocol
,Rationale: The protocol is the document that describes the
objective(s), design, methodology, statistical considerations, and
organization of a clinical trial. It is the master plan that guides the
conduct of the study.
Question 2
What is the primary purpose of an Investigational Brochure (IB)?
A. To list the study endpoints
B. To document adverse events
C. To provide information on the safety and efficacy of an
investigational product
D. To serve as a patient consent form
Answer: C. To provide information on the safety and efficacy of an
investigational product
Rationale: The Investigator's Brochure (IB) is a comprehensive
document that summarizes the physical, chemical, pharmaceutical,
pharmacological, toxicological, and clinical data for an investigational
product. It is intended to provide investigators and other study
personnel with the information necessary to understand the rationale
and risks of the trial.
Question 3
What is a cross-over study design?
, A. A study where participants are assigned to different treatments and
followed over time
B. A study where participants receive different treatments in a specific
sequence
C. A study where participants are observed without any intervention
D. A study where data is collected from medical records
Answer: B. A study where participants receive different treatments in a
specific sequence
Rationale: In a cross-over design, each participant receives multiple
treatments in a random order, with a washout period between
treatments. This allows each participant to serve as their own control.
Question 4
What is the purpose of a placebo in a clinical trial?
A. To provide a treatment that is known to be effective
B. To serve as a control for comparison with the investigational
product
C. To ensure all participants receive some treatment
D. To reduce the cost of the trial
Answer: B. To serve as a control for comparison with the
investigational product
Rationale: A placebo is an inactive substance that looks identical to
the investigational product. It is used as a control to distinguish the
true effect of the investigational product from the placebo effect.
Questions and Answers
This comprehensive practice exam is designed to help you prepare for
the ACRP Certified Clinical Research Coordinator (CCRC) exam. The
questions are based on the official ACRP Exam Content Outline (ECO)
which outlines the six domains tested on the exam.
EXAM OVERVIEW
The CCRC exam covers the following domains, with the percentage of
questions allocated to each domain as shown below:
Domain Percentag
e
I. Scientific 8%
Concepts and
Research Design
II. Ethical and 22%
Participant Safety
Considerations
,III. Product 14%
Development and
Regulation
IV. Clinical Trial 22%
Operations (GCPs)
V. Study and Site 22%
Management
VI. Data 12%
Management and
Informatics
SECTION 1: SCIENTIFIC CONCEPTS AND
RESEARCH DESIGN (Questions 1-8)
Question 1
Which document provides the detailed design of a clinical trial,
including the background, objectives, and statistical methods?
A. Investigator's Brochure (IB)
B. Case Report Form (CRF)
C. Protocol
D. Informed Consent Form (ICF)
Answer: C. Protocol
,Rationale: The protocol is the document that describes the
objective(s), design, methodology, statistical considerations, and
organization of a clinical trial. It is the master plan that guides the
conduct of the study.
Question 2
What is the primary purpose of an Investigational Brochure (IB)?
A. To list the study endpoints
B. To document adverse events
C. To provide information on the safety and efficacy of an
investigational product
D. To serve as a patient consent form
Answer: C. To provide information on the safety and efficacy of an
investigational product
Rationale: The Investigator's Brochure (IB) is a comprehensive
document that summarizes the physical, chemical, pharmaceutical,
pharmacological, toxicological, and clinical data for an investigational
product. It is intended to provide investigators and other study
personnel with the information necessary to understand the rationale
and risks of the trial.
Question 3
What is a cross-over study design?
, A. A study where participants are assigned to different treatments and
followed over time
B. A study where participants receive different treatments in a specific
sequence
C. A study where participants are observed without any intervention
D. A study where data is collected from medical records
Answer: B. A study where participants receive different treatments in a
specific sequence
Rationale: In a cross-over design, each participant receives multiple
treatments in a random order, with a washout period between
treatments. This allows each participant to serve as their own control.
Question 4
What is the purpose of a placebo in a clinical trial?
A. To provide a treatment that is known to be effective
B. To serve as a control for comparison with the investigational
product
C. To ensure all participants receive some treatment
D. To reduce the cost of the trial
Answer: B. To serve as a control for comparison with the
investigational product
Rationale: A placebo is an inactive substance that looks identical to
the investigational product. It is used as a control to distinguish the
true effect of the investigational product from the placebo effect.
